A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Prof. Melanie Davies, MBChB
Diabetes Research Centre Leicester Diabetes Centre - Bloom University of Leicester
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
321 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Buenos Aires, Argentina
Not, yet, recruiting - Research Site
Buenos Aires, Argentina
Not, yet, recruiting - Research Site
CABA, Argentina
Not, yet, recruiting - Research Site
CABA, Argentina
Not, yet, recruiting - Research Site
Caba, Argentina
Not, yet, recruiting - Research Site
Capital Federal, Argentina
Not, yet, recruiting - Research Site
Granadero Baigorria, Argentina
Not, yet, recruiting - Research Site
Lanus, Argentina
Not, yet, recruiting - Research Site
Rosario, Argentina
Not, yet, recruiting - Research Site
Rosario, Argentina
Not, yet, recruiting - Research Site
San Nicolás, Argentina
Not, yet, recruiting - Research Site
San Vicente, Argentina
Not, yet, recruiting
- Research Site
Botany, Australia
Not, yet, recruiting - Research Site
Camberwell, Australia
Not, yet, recruiting - Research Site
Kotara, Australia
Not, yet, recruiting - Research Site
Maroubra, Australia
Not, yet, recruiting - Research Site
St Albans, Australia
Recruiting - Research Site
St Leonards, Australia
Not, yet, recruiting
- Research Site
Belém, Brazil
Not, yet, recruiting - Research Site
Brasília, Brazil
Not, yet, recruiting - Research Site
Campinas, Brazil
Not, yet, recruiting - Research Site
Campinas, Brazil
Not, yet, recruiting - Research Site
Curitiba, Brazil
Not, yet, recruiting - Research Site
Fortaleza, Brazil
Not, yet, recruiting - Research Site
Porto Alegre, Brazil
Not, yet, recruiting - Research Site
São José dos Campos, Brazil
Not, yet, recruiting - Research Site
São Paulo, Brazil
Not, yet, recruiting - Research Site
São Paulo, Brazil
Not, yet, recruiting - Research Site
São Paulo, Brazil
Not, yet, recruiting
- Research Site
Calgary, Alberta, Canada
Not, yet, recruiting - Research Site
Calgary, Alberta, Canada
Not, yet, recruiting - Research Site
Vancouver, British Columbia, Canada
Not, yet, recruiting - Research Site
Victoria, British Columbia, Canada
Not, yet, recruiting - Research Site
Moncton, New Brunswick, Canada
Not, yet, recruiting - Research Site
Truro, Nova Scotia, Canada
Recruiting - Research Site
Brampton, Ontario, Canada
Not, yet, recruiting - Research Site
Hamilton, Ontario, Canada
Not, yet, recruiting - Research Site
Niagara Falls, Ontario, Canada
Not, yet, recruiting - Research Site
North York, Ontario, Canada
Not, yet, recruiting - Research Site
Sarnia, Ontario, Canada
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jun 2026
- Primary completion
- 31 Jul 2028
- Completion
- 30 Jul 2029
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 4,500
- Registry id
- NCT07667803
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.